Squamous Lntraepithelial Lesions of Vulva

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Squamous Lntraepithelial Lesions of Vulva trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2

NCT03937791

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Background: Human papillomavirus (HPV) can cause vulvar high-grade squamous intraepithelial lesions (HSIL). Sometimes, this can become cancer. Researchers want…

United States1 participantsStarted 2019-10-09

Treatment: E7 T Cell Receptor (TCR)